NIT, IISER researchers patent cotarnine-derived oral cancer formulation – FinSiddhi

NIT, IISER researchers patent cotarnine-derived oral cancer formulation

The patented formulation showed activity against oral cancer cells, researchers said, but further preclinical studies are needed to establish its safety and efficacy.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.